ArticleEJHaem2025

Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical Models.

Natsumi Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.